DJIA 16,790.19 13.76 0.08%
NASDAQ 4,748.36 -32.90 -0.69%
S&P 500 1,979.92 -7.13 -0.36%
market minute promo

Gilead Sciences (NASDAQ: GILD)

company name or ticker
Company Photos
(Click to zoom)

Merck's (MRK) All-Oral Ribavirin-Free HCV Data Published

Biotech Bears Spark Good Vibes For These ETFs

Social Media Beat: The Three Gs -- GE, Google And Gilead

Notable Tuesday Option Activity: GILD, HP, T

Why AbbVie Inc.'s Shares Slumped 13% in September

Risk of patent expiration on Humira and Gilead Sciences positive hepatitis C trial results weighed on shares last month.

3 Biotech Stocks That Have Been Unfairly Beaten Down

Biotech stocks have been under attack recently, but which names have fallen the hardest for reasons that have nothing to do with the companies' performance?

'Fast Money' Recap: Have Markets Risen Too Far Too Fast?

Gilead's Letairis Gets FDA Nod in Combination with Adcirca

Tweet This Hillary: Pros See Biotech ETFs As A Buy

ContraVir Soars 150% as New HBV Drug is 60x More Active than Gilead's Viread

See More Articles...